GUCY2D: A Potential Drug Target and Biomarker (G3000)

GUCY2D: A Potential Drug Target and Biomarker

Gucy2D is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and pancreas. Its full name is Gucy2D-containing protein 2D, and it is a member of the Gucy family of proteins that are characterized by the presence of a unique transmembrane domain and a unique N-terminal signal domain. Gucy2D has been shown to play a role in various physiological processes in the body, including cell signaling, metabolism, and inflammation. As a result, Gucy2D has potential as a drug target or biomarker.

Gucy2D is involved in a number of signaling pathways that are important for various physiological processes in the body. For example, Gucy2D has been shown to be involved in the regulation of cell signaling pathways that are important for brain development, function, and disease. One of the key functions of Gucy2D is its role in the Wnt signaling pathway, a pathway that is important for the development and maintenance of tissues in the body.

In addition to its role in the Wnt pathway, Gucy2D is also involved in the regulation of cell signaling pathways that are important for metabolism and inflammation. For example, Gucy2D has been shown to be involved in the regulation of theNotch signaling pathway, a pathway that is important for the regulation of metabolism and inflammation.

Gucy2D is also involved in the regulation of various cellular processes that are important for maintaining cellular homeostasis. For example, Gucy2D has been shown to be involved in the regulation of the actinin signaling pathway, a pathway that is important for the regulation of cell shape and movement.

Gucy2D has also been shown to play a role in the regulation of cellular processes that are important for the development and maintenance of tissues in the body. For example, Gucy2D has been shown to be involved in the regulation of the TGF-β signaling pathway, a pathway that is important for the regulation of cell growth and differentiation.

In addition to its role in various signaling pathways, Gucy2D is also involved in the regulation of cellular processes that are important for inflammation and immune response. For example, Gucy2D has been shown to be involved in the regulation of the NF-kappa-B signaling pathway, a pathway that is important for the regulation of inflammation and immune response.

Gucy2D has also been shown to play a role in the regulation of cellular processes that are important for the regulation of cellular interactions and adhesion. For example, Gucy2D has been shown to be involved in the regulation of the cadherin signaling pathway, a pathway that is important for the regulation of cell-cell interactions and adhesion.

Gucy2D has also been shown to play a role in the regulation of cellular processes that are important for the development and maintenance of tissues in the body. For example, Gucy2D has been shown to be involved in the regulation of the angiogenesis signaling pathway, a pathway that is important for the development and maintenance of tissues in the body.

Gucy2D has been shown to play a role in the regulation of various physiological processes in the body, including cell signaling, metabolism, and inflammation. As a result, Gucy2D has potential as a drug target or biomarker. Further research is needed to fully understand the role of Gucy2D in various physiological processes and to determine its potential as a drug target or biomarker.

Protein Name: Guanylate Cyclase 2D, Retinal

Functions: Catalyzes the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors. Plays an essential role in phototransduction, by mediating cGMP replenishment (PubMed:21928830, PubMed:30319355, PubMed:26100624, PubMed:9600905, PubMed:15123990). May also participate in the trafficking of membrane-asociated proteins to the photoreceptor outer segment membrane (By similarity)

The "GUCY2D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GUCY2D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GUCY2EP | GUCY2F | GUCY2GP | GUF1 | GUK1 | GULOP | GULP1 | GUSB | GUSBP1 | GUSBP11 | GUSBP12 | GUSBP14 | GUSBP15 | GUSBP17 | GUSBP2 | GUSBP3 | GUSBP4 | GUSBP5 | GUSBP8 | GVINP1 | GVQW3 | GXYLT1 | GXYLT1P3 | GXYLT1P4 | GXYLT1P6 | GXYLT2 | GYG1 | GYG2 | GYPA | GYPB | GYPC | GYPE | GYS1 | GYS2 | GZF1 | GZMA | GZMB | GZMH | GZMK | GZMM | H1-0 | H1-1 | H1-10 | H1-10-AS1 | H1-2 | H1-3 | H1-4 | H1-5 | H1-6 | H1-7 | H1-8 | H1-9P | H19 | H19-ICR | H2AB1 | H2AB2 | H2AB3 | H2AC1 | H2AC11 | H2AC12 | H2AC13 | H2AC14 | H2AC15 | H2AC16 | H2AC17 | H2AC18 | H2AC20 | H2AC21 | H2AC25 | H2AC3P | H2AC4 | H2AC6 | H2AC7 | H2AJ | H2AP | H2AX | H2AZ1 | H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18 | H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7